2020 Q3 Form 10-K Financial Statement

#000156459020041865 Filed on August 31, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2019 Q4
Revenue $46.21M $42.11M $39.08M
YoY Change 31.35% 32.91% 50.31%
Cost Of Revenue $12.11M $10.10M $9.787M
YoY Change 32.35% 18.99% 36.4%
Gross Profit $34.10M $32.01M $29.29M
YoY Change 31.0% 38.0% 55.62%
Gross Profit Margin 73.8% 76.02% 74.96%
Selling, General & Admin $30.10M $27.34M $24.24M
YoY Change 44.69% 44.65% 82.8%
% of Gross Profit 88.26% 85.42% 82.75%
Research & Development $17.79M $14.93M $12.99M
YoY Change 54.46% 58.03% 111.11%
% of Gross Profit 52.15% 46.64% 44.35%
Depreciation & Amortization $920.0K $1.050M $1.120M
YoY Change -7.07% -33.54% 40.0%
% of Gross Profit 2.7% 3.28% 3.82%
Operating Expenses $47.88M $42.27M $37.23M
YoY Change 48.17% 49.11% 91.77%
Operating Profit -$13.78M -$10.26M -$7.938M
YoY Change 119.3% 99.13% 1245.42%
Interest Expense $30.00K $750.0K $21.00K
YoY Change -80.52% -86.54%
% of Operating Profit
Other Income/Expense, Net $830.0K $764.0K $360.0K
YoY Change 29.89% 28.19% -47.52%
Pretax Income -$12.95M -$9.497M -$7.578M
YoY Change 129.42% 108.4% -7993.75%
Income Tax $0.00 $1.000K $0.00
% Of Pretax Income
Net Earnings -$12.95M -$9.498M -$7.578M
YoY Change 127.37% 111.16% -7529.41%
Net Earnings / Revenue -28.03% -22.56% -19.39%
Basic Earnings Per Share
Diluted Earnings Per Share -$161.4K -$333.7K -$104.8K
COMMON SHARES
Basic Shares Outstanding 80.18M 72.58M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2020 Q2 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $700.3M $697.6M $383.0M
YoY Change 344.37% 329.9%
Cash & Equivalents $564.2M $573.6M $314.9M
Short-Term Investments $136.2M $124.0M $68.10M
Other Short-Term Assets $1.684B $1.671B $1.508B
YoY Change 13.77%
Inventory
Prepaid Expenses
Receivables $12.00M $4.252M $10.70M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.397B $2.379B $1.901B
YoY Change 45.5% 57.26%
LONG-TERM ASSETS
Property, Plant & Equipment $21.71M $13.87M $7.500M
YoY Change 185.64% 111.47%
Goodwill $0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $17.50M $10.70M $6.400M
YoY Change 136.49% 61.12%
Total Long-Term Assets $82.60M $24.57M $13.80M
YoY Change 450.67% 86.13%
TOTAL ASSETS
Total Short-Term Assets $2.397B $2.379B $1.901B
Total Long-Term Assets $82.60M $24.57M $13.80M
Total Assets $2.479B $2.404B $1.915B
YoY Change 49.15% 57.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.600M $3.478M $6.000M
YoY Change 15.79% -31.31%
Accrued Expenses $8.335M $10.84M $10.90M
YoY Change 2.9% 65.36%
Deferred Revenue $5.891M
YoY Change 69.82%
Short-Term Debt $2.300M $2.300M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.702B $1.677B $1.518B
YoY Change 14.36% 24.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $58.10M $13.83M $1.375M
YoY Change 1715.63% 855.56%
Total Long-Term Liabilities $58.10M $13.83M $1.375M
YoY Change 1715.63% 855.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.702B $1.677B $1.518B
Total Long-Term Liabilities $58.10M $13.83M $1.375M
Total Liabilities $1.760B $1.693B $1.522B
YoY Change 18.01% 25.18%
SHAREHOLDERS EQUITY
Retained Earnings -$161.7M -$148.7M -$130.9M
YoY Change 26.43%
Common Stock $2.000K $2.000K $2.000K
YoY Change 100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $718.8M $710.7M $393.4M
YoY Change
Total Liabilities & Shareholders Equity $2.479B $2.404B $1.915B
YoY Change 49.15% 57.51%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2019 Q4
OPERATING ACTIVITIES
Net Income -$12.95M -$9.498M -$7.578M
YoY Change 127.37% 111.16% -7529.41%
Depreciation, Depletion And Amortization $920.0K $1.050M $1.120M
YoY Change -7.07% -33.54% 40.0%
Cash From Operating Activities -$2.356M -$1.100M -$1.770M
YoY Change -1.01% -37.85% -2312.5%
INVESTING ACTIVITIES
Capital Expenditures $5.894M -$5.850M -$1.150M
YoY Change 202.88% 207.89% 0.88%
Acquisitions
YoY Change
Other Investing Activities -$67.25M -$21.76M $146.6M
YoY Change -50.54% -80.86% -173.63%
Cash From Investing Activities -$73.46M -$27.62M $145.4M
YoY Change -195.88% -76.1% -172.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.327M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 37.28M 609.3M 253.5M
YoY Change -72.68% 393.32% -5.77%
NET CHANGE
Cash From Operating Activities -2.356M -1.100M -1.770M
Cash From Investing Activities -73.46M -27.62M 145.4M
Cash From Financing Activities 37.28M 609.3M 253.5M
Net Change In Cash -38.54M 580.6M 397.1M
YoY Change -118.29% 9309.72% 476.87%
FREE CASH FLOW
Cash From Operating Activities -$2.356M -$1.100M -$1.770M
Capital Expenditures $5.894M -$5.850M -$1.150M
Free Cash Flow -$8.250M $4.750M -$620.0K
YoY Change 90.71% 3553.85% -150.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 bill Unbilled Revenue Current
UnbilledRevenueCurrent
4795000
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12326000
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2020 bill Strategic Partnership Agreement Period
StrategicPartnershipAgreementPeriod
P10Y
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q2 us-gaap Restricted Cash Current Asset Statement Of Financial Position Extensible List
RestrictedCashCurrentAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsCurrent
CY2018Q2 us-gaap Restricted Cash Current Asset Statement Of Financial Position Extensible List
RestrictedCashCurrentAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsCurrent
CY2020Q2 us-gaap Restricted Cash Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashNoncurrentAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M13D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M3D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y2M15D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y1M13D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1676847000
CY2020Q2 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
1644250000
CY2020Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2622000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13827000
CY2020Q2 us-gaap Liabilities
Liabilities
1693296000
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
CY2020Q2 us-gaap Restricted Cash Current Asset Statement Of Financial Position Extensible List
RestrictedCashCurrentAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsCurrent
CY2019Q2 us-gaap Restricted Cash Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashNoncurrentAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2020 dei Entity Registrant Name
EntityRegistrantName
BILL.COM HOLDINGS, INC.
CY2018Q2 us-gaap Restricted Cash Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashNoncurrentAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2020Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
123974000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
573643000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
90306000
CY2020 dei Security12b Title
Security12bTitle
Common Stock, $0.00001 par value
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4252000
CY2019Q2 us-gaap Funds Held For Clients
FundsHeldForClients
1329306000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
1513100000
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3469000
CY2019Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
71969000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4398000
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
857044000
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14672000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
326000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-117656000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-102657000
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1447000
CY2019Q2 us-gaap Liabilities
Liabilities
1352648000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2420000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-148747000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
710719000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2404015000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-417822000
CY2020 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
314944000
CY2019 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
414293000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-7314000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-7195000
CY2018 us-gaap Profit Loss
ProfitLoss
-7195000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3154000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2314000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
4082000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
1545000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.500
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.460
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.450
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0035
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0219
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0205
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.006
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.510
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.551
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0188
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0289
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0289
CY2019Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P6M29D
CY2018Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P1Y14D
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Entity File Number
EntityFileNumber
001-39149
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-2661725
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
1800 Embarcadero Road
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
Palo Alto
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94303
CY2020 dei City Area Code
CityAreaCode
650
CY2020 dei Local Phone Number
LocalPhoneNumber
621-7700
CY2020 dei Trading Symbol
TradingSymbol
BILL
CY2020 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Small Business
EntitySmallBusiness
false
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2019Q4 dei Entity Public Float
EntityPublicFloat
1100000000
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
80180550
CY2020Q2 bill Unbilled Revenue Current
UnbilledRevenueCurrent
6549000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26781000
CY2020Q2 us-gaap Funds Held For Clients
FundsHeldForClients
1644250000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
2379449000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13866000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6557000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10700000
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6641000
CY2020Q2 us-gaap Assets
Assets
2404015000
CY2019Q2 us-gaap Assets
Assets
1526298000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3478000
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5063000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12387000
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4333000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8541000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
573643000
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22401000
CY2020Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
35000
CY2019Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
256000
CY2018Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
256000
CY2019Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
550000
CY2019Q2 bill Restricted Cash And Cash Equivalents Included In Funds Held For Customers
RestrictedCashAndCashEquivalentsIncludedInFundsHeldForCustomers
892056000
CY2018Q2 bill Restricted Cash And Cash Equivalents Included In Funds Held For Customers
RestrictedCashAndCashEquivalentsIncludedInFundsHeldForCustomers
568911000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
591568000
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1400000
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6556000
CY2019Q2 bill Redeemable Convertible Preferred Stock Warrant Liabilities Current
RedeemableConvertiblePreferredStockWarrantLiabilitiesCurrent
688000
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5891000
CY2020Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2300000
CY2019Q2 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
1329306000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1349415000
CY2019Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1786000
CY2020Q2 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
0
CY2020Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2020Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2019Q2 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
106090000
CY2019Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
52435000
CY2019Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
52435000
CY2019Q2 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
280513000
CY2019Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
276307000
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1526298000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
157600000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108351000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64865000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39144000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
29918000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19372000
CY2020 us-gaap Gross Profit
GrossProfit
118456000
CY2019 us-gaap Gross Profit
GrossProfit
78433000
CY2018 us-gaap Gross Profit
GrossProfit
45493000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53405000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28924000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17986000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
45356000
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
30114000
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
19290000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29198000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16034000
CY2018 us-gaap Operating Expenses
OperatingExpenses
53310000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3160000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2333000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
632000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-31091000
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.70
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.94
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44106000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7797000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-31091000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-7195000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31038000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-156000
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.01
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7155000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
2094000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
679000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-177000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7372000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-7314000
CY2019 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
176000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28997000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6811000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
-96832000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
755000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1545000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-177000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-7195000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-101904000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1702000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4082000
CY2019 bill Issuance Of Stock Warrants
IssuanceOfStockWarrants
274000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
503000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-7314000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-102657000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
276307000
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1405000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
225481000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13460000
CY2020 bill Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
144000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18064000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2094000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-31091000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
710719000
CY2020 us-gaap Profit Loss
ProfitLoss
-31091000
CY2019 us-gaap Profit Loss
ProfitLoss
-7314000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4257000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
18064000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
3815000
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1319000
CY2020 bill Revaluation Of Warrant Liabilities And Forfeiture Of Warrants
RevaluationOfWarrantLiabilitiesAndForfeitureOfWarrants
717000
CY2019 bill Revaluation Of Warrant Liabilities And Forfeiture Of Warrants
RevaluationOfWarrantLiabilitiesAndForfeitureOfWarrants
25000
CY2018 bill Revaluation Of Warrant Liabilities And Forfeiture Of Warrants
RevaluationOfWarrantLiabilitiesAndForfeitureOfWarrants
182000
CY2019 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
274000
CY2019 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-176000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1054000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2098000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
279000
CY2020 bill Increase Decrease In Unbilled Revenue
IncreaseDecreaseInUnbilledRevenue
554000
CY2019 bill Increase Decrease In Unbilled Revenue
IncreaseDecreaseInUnbilledRevenue
1748000
CY2018 bill Increase Decrease In Unbilled Revenue
IncreaseDecreaseInUnbilledRevenue
503000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10434000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5690000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3477000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4928000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
995000
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2828000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1596000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3171000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-563000
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
9755000
CY2019 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4336000
CY2018 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1642000
CY2020 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
12991000
CY2019 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
302000
CY2018 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
35000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3258000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3949000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
47000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
771000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4430000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8356000
CY2020 bill Payment To Acquire Corporate And Customer Fund Short Term Investments
PaymentToAcquireCorporateAndCustomerFundShortTermInvestments
1088611000
CY2019 bill Payment To Acquire Corporate And Customer Fund Short Term Investments
PaymentToAcquireCorporateAndCustomerFundShortTermInvestments
830622000
CY2018 bill Payment To Acquire Corporate And Customer Fund Short Term Investments
PaymentToAcquireCorporateAndCustomerFundShortTermInvestments
726788000
CY2020 bill Proceeds From Maturities Of Corporate And Customer Fund Short Term Investments
ProceedsFromMaturitiesOfCorporateAndCustomerFundShortTermInvestments
806000000
CY2019 bill Proceeds From Maturities Of Corporate And Customer Fund Short Term Investments
ProceedsFromMaturitiesOfCorporateAndCustomerFundShortTermInvestments
694303000
CY2018 bill Proceeds From Maturities Of Corporate And Customer Fund Short Term Investments
ProceedsFromMaturitiesOfCorporateAndCustomerFundShortTermInvestments
290828000
CY2020 bill Proceeds From Sale Of Corporate And Customer Fund Short Term Investments
ProceedsFromSaleOfCorporateAndCustomerFundShortTermInvestments
46159000
CY2019 bill Proceeds From Sale Of Corporate And Customer Fund Short Term Investments
ProceedsFromSaleOfCorporateAndCustomerFundShortTermInvestments
54715000
CY2018 bill Proceeds From Sale Of Corporate And Customer Fund Short Term Investments
ProceedsFromSaleOfCorporateAndCustomerFundShortTermInvestments
16498000
CY2020 bill Increase Decrease In Restricted Cash And Cash Equivalents And Other Receivables Included In Funds Held For Customers
IncreaseDecreaseInRestrictedCashAndCashEquivalentsAndOtherReceivablesIncludedInFundsHeldForCustomers
959000
CY2019 bill Increase Decrease In Restricted Cash And Cash Equivalents And Other Receivables Included In Funds Held For Customers
IncreaseDecreaseInRestrictedCashAndCashEquivalentsAndOtherReceivablesIncludedInFundsHeldForCustomers
10203000
CY2018 bill Increase Decrease In Restricted Cash And Cash Equivalents And Other Receivables Included In Funds Held For Customers
IncreaseDecreaseInRestrictedCashAndCashEquivalentsAndOtherReceivablesIncludedInFundsHeldForCustomers
-3686000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11437000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2743000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1313000
CY2020 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
639000
CY2019 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1556000
CY2018 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
733000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-249487000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-96106000
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
225481000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
308176000
CY2019 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
85160000
CY2018 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
55805000
CY2018 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
263671000
CY2020 bill Proceeds From Lines Of Credit And Bank Borrowings
ProceedsFromLinesOfCreditAndBankBorrowings
2300000
CY2018 bill Proceeds From Lines Of Credit And Bank Borrowings
ProceedsFromLinesOfCreditAndBankBorrowings
9500000
CY2019 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
9500000
CY2018 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
3387000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12232000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1702000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
693000
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
144000
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
151000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
863126000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
491655000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
326282000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
609209000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
391600000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-99896000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
983168000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
591568000
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
691464000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1592377000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
983168000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
591568000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
174000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
872000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
436000
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1908000
CY2020 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
276307000
CY2020 bill Accrued Offering And Debt Issuance Costs
AccruedOfferingAndDebtIssuanceCosts
664000
CY2020 bill Reclassification Of Redeemable Convertible Preferred Stock Warrant Liabilities Into Additional Paid In Capital Upon Initial Public Offering
ReclassificationOfRedeemableConvertiblePreferredStockWarrantLiabilitiesIntoAdditionalPaidInCapitalUponInitialPublicOffering
1405000
CY2020 bill Receivable From Broker Assisted Exercises Of Stock Options
ReceivableFromBrokerAssistedExercisesOfStockOptions
1228000
CY2019 bill Accrued Offering And Debt Issuance Costs
AccruedOfferingAndDebtIssuanceCosts
470000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
90306000
CY2020Q2 bill Restricted Cash And Cash Equivalents Included In Funds Held For Customers
RestrictedCashAndCashEquivalentsIncludedInFundsHeldForCustomers
1018699000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1592377000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
983168000
CY2019Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
225500000
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1400000
CY2020Q2 bill Proceeds From Follow On Offering
ProceedsFromFollowOnOffering
307500000
CY2020 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
the Company filed an amendment to its amended and restated certificate of incorporation to effect a reverse split of shares of the Company’s issued and outstanding redeemable convertible preferred stock, common stock and non-voting common stock on a 2-for-1 basis
CY2019Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of Credit Risk </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term investments, and accounts receivable. The Company maintains its cash and cash equivalents and short-term investments with major financial institutions that may at times exceed federally insured limits. Management believes that these financial institutions are financially sound and the Company has not experienced material losses. There were no customers that exceeded 10% of the Company’s total revenue during the years ended June 30, 2020, 2019 and 2018.</p>
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make various estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and the accompanying notes. Management regularly assesses these estimates, including those related to fair value of common stock prior to the Company’s IPO and stock-based compensation, fair value of redeemable convertible preferred stock warrant liabilities up until the date of the Company’s IPO, useful lives of property and equipment, the attribution method used to recognize revenue on annual contracts, variable consideration used in revenue recognition for certain financial institutions, reserve for sales tax obligations, reserve for losses on funds held for customers, and income taxes. The Company evaluates these estimates and assumptions and adjusts the estimates and assumptions accordingly. Actual results could differ from those estimates, and such differences may be material to the consolidated financial statements. </p>
CY2020 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2019 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2018 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020 bill Employee Stock Purchase Plan Purchase Rights Offering Period
EmployeeStockPurchasePlanPurchaseRightsOfferingPeriod
P1Y
CY2020 us-gaap Advertising Expense
AdvertisingExpense
5800000
CY2019 us-gaap Advertising Expense
AdvertisingExpense
3700000
CY2018 us-gaap Advertising Expense
AdvertisingExpense
800000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-99896000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3949000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-96106000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
491655000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
391600000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
591568000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
983168000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8356000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-417822000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
326282000
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
691464000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
591568000
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
152300000
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
13000000.0
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
139300000
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5600000
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5600000
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
123395000
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
590000
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
11000
CY2020Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
123974000
CY2019 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
1100000
CY2018 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
400000
CY2020Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2020Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
2300000
CY2019 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
1400000
CY2018 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
1000000.0
CY2020 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
400000
CY2020Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2019Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2019Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2019Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
688000
CY2018Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
663000
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
717000
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
319000
CY2020 bill Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Reclassification To Additional Paid In Capital
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToAdditionalPaidInCapital
1405000
CY2019 bill Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Forfeiture Of Warrants
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityForfeitureOfWarrants
294000
CY2019Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
688000
CY2020Q2 bill Percentage Of Debt Securities Available For Sale Maturing Within One Year
PercentageOfDebtSecuritiesAvailableForSaleMaturingWithinOneYear
0.83
CY2020Q2 bill Percentage Of Debt Securities Available For Sale Maturing After One Year Through Two Years
PercentageOfDebtSecuritiesAvailableForSaleMaturingAfterOneYearThroughTwoYears
0.17
CY2020Q2 bill Funds Held For Customers Debt Securities Accumulated Gross Unrealized Loss Before Tax
FundsHeldForCustomersDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
11000
CY2019Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
71969000
CY2020Q2 bill Funds Held For Customers Debt Securities Current
FundsHeldForCustomersDebtSecuritiesCurrent
628784000
CY2019Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
71894000
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
75000
CY2019Q2 bill Percentage Of Debt Securities Available For Sale Maturing Within One Year
PercentageOfDebtSecuritiesAvailableForSaleMaturingWithinOneYear
1
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
12056000
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
11000
CY2020 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0
CY2019 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0
CY2018 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0
CY2020Q2 bill Funds Held For Clients Gross
FundsHeldForClientsGross
1649386000
CY2019Q2 bill Funds Held For Clients Gross
FundsHeldForClientsGross
1333597000
CY2020Q2 us-gaap Funds Held For Clients
FundsHeldForClients
1644250000
CY2019Q2 us-gaap Funds Held For Clients
FundsHeldForClients
1329306000
CY2020Q2 bill Funds Held For Customers Debt Securities Amortized Cost
FundsHeldForCustomersDebtSecuritiesAmortizedCost
626740000
CY2020Q2 bill Funds Held For Customers Debt Securities Accumulated Gross Unrealized Gain Before Tax
FundsHeldForCustomersDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2055000
CY2019Q2 bill Funds Held For Customers Debt Securities Amortized Cost
FundsHeldForCustomersDebtSecuritiesAmortizedCost
437979000
CY2019Q2 bill Funds Held For Customers Debt Securities Accumulated Gross Unrealized Gain Before Tax
FundsHeldForCustomersDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
441000
CY2019Q2 bill Funds Held For Customers Debt Securities Accumulated Gross Unrealized Loss Before Tax
FundsHeldForCustomersDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
13000
CY2019Q2 bill Funds Held For Customers Debt Securities Current
FundsHeldForCustomersDebtSecuritiesCurrent
438407000
CY2020Q2 bill Funds Held For Customers Debt Securities Percentage Mature With In One Year
FundsHeldForCustomersDebtSecuritiesPercentageMatureWithInOneYear
1
CY2019Q2 bill Funds Held For Customers Debt Securities Percentage Mature With In One Year
FundsHeldForCustomersDebtSecuritiesPercentageMatureWithInOneYear
1
CY2020Q2 bill Funds Held For Customers Debt Securities Fair Value
FundsHeldForCustomersDebtSecuritiesFairValue
66781000
CY2020Q2 bill Funds Held For Customers Debt Securities Unrealized Losses
FundsHeldForCustomersDebtSecuritiesUnrealizedLosses
11000
CY2019Q2 bill Funds Held For Customers Debt Securities Fair Value
FundsHeldForCustomersDebtSecuritiesFairValue
58092000
CY2019Q2 bill Funds Held For Customers Debt Securities Unrealized Losses
FundsHeldForCustomersDebtSecuritiesUnrealizedLosses
13000
CY2020Q2 bill Funds Held For Customers For Sale Realized Gain Loss
FundsHeldForCustomersForSaleRealizedGainLoss
0
CY2019Q2 bill Funds Held For Customers For Sale Realized Gain Loss
FundsHeldForCustomersForSaleRealizedGainLoss
0
CY2018Q2 bill Funds Held For Customers For Sale Realized Gain Loss
FundsHeldForCustomersForSaleRealizedGainLoss
0
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6556000
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27661000
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18022000
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13795000
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11465000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13866000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6557000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4300000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3200000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2300000
CY2020Q2 bill Accrued Sales And Use Tax
AccruedSalesAndUseTax
2976000
CY2019Q2 bill Accrued Sales And Use Tax
AccruedSalesAndUseTax
2881000
CY2020Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
1107000
CY2019Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
494000
CY2020Q2 bill Accrued License Fees Current
AccruedLicenseFeesCurrent
473000
CY2019Q2 bill Accrued License Fees Current
AccruedLicenseFeesCurrent
131000
CY2020Q2 bill Non Sufficient Funds Reserve
NonSufficientFundsReserve
260000
CY2019Q2 bill Non Sufficient Funds Reserve
NonSufficientFundsReserve
147000
CY2020Q2 bill Long Term Payable For Purchase Of Software Current
LongTermPayableForPurchaseOfSoftwareCurrent
613000
CY2019Q2 bill Long Term Payable For Purchase Of Software Current
LongTermPayableForPurchaseOfSoftwareCurrent
512000
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3112000
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2391000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8541000
CY2019Q2 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
106090000
CY2019Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
52435000
CY2019Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
52435000
CY2019Q2 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
280513000
CY2019 bill Proceeds From Issuance Of Convertible Preferred Stock Gross
ProceedsFromIssuanceOfConvertiblePreferredStockGross
280513000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P4Y
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2020 bill Share Based Compensation Arrangement By Share Based Payment Accelerated Vesting Options Vesting Percentage
ShareBasedCompensationArrangementByShareBasedPaymentAcceleratedVestingOptionsVestingPercentage
0.50
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10027000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.90
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
75223000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2937000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
18.78
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3291000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.09
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
654000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
8.83
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9019000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.53
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
718563000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
8135000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
10.34
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
649756000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2584000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
6.23
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
217024000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.04
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.24
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.02
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
191300000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3800000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
700000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
3207000
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
1058000
CY2020 us-gaap Interest Expense
InterestExpense
229000
CY2019 us-gaap Interest Expense
InterestExpense
825000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
40400000
CY2020 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12200000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1700000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
700000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18064000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4082000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1545000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0
CY2020Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2019Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
126000
CY2020Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.50
CY2020 bill Class Of Warrant Exercisable Period
ClassOfWarrantExercisablePeriod
P5Y
CY2020 bill Class Of Warrant Exercisable Period Ends
ClassOfWarrantExercisablePeriodEnds
2023-09
CY2020 bill Class Of Warrant Or Right Issued Or Issuable Number
ClassOfWarrantOrRightIssuedOrIssuableNumber
0
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
4092000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31038000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7470000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7185000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018 us-gaap Interest Expense
InterestExpense
427000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
717000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-49000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3160000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2333000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
632000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-31038000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-7470000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-7185000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
53000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
20000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
10000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
53000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
20000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
10000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-142000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-34000
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-176000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-156000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-6518000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1569000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1976000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-31047000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
390000
CY2020 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
6411000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
297000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-156000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000
CY2019 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
2111000
CY2018 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
909000
CY2018 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
12227000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
43716000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3029000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-9753000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
313000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
105000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
124000
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
3933000
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1631000
CY2020Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
904000
CY2019Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
84000
CY2020Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
128000
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2542000
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
700000
CY2020Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
68694000
CY2019Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
26690000
CY2020Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
12226000
CY2019Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
5649000
CY2020Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
88427000
CY2019Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
34754000
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
85569000
CY2019Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
33253000
CY2020Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2858000
CY2019Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1501000
CY2020Q2 us-gaap Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
2182000
CY2019Q2 us-gaap Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
1229000
CY2019Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
143000
CY2020Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
676000
CY2019Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
129000
CY2020Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2858000
CY2019Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1501000
CY2020Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2019Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
52300000
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
3700000
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
10000000.0
CY2020 bill Operating Loss Carryforwards Expiration Year
OperatingLossCarryforwardsExpirationYear
2026
CY2020 bill Tax Credit Carryforward Expiration Description
TaxCreditCarryforwardExpirationDescription
federal tax credits will expire at various dates beginning in 2027.
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5800000
CY2019Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2700000
CY2020 bill Non Cancelable Operating Leases Expiration Month And Year
NonCancelableOperatingLeasesExpirationMonthAndYear
2031-06
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
5300000
CY2018Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1457000
CY2017Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
835000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
3078000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1028000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
17000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
207000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
622000
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5787000
CY2019Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2692000
CY2018Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1457000
CY2019Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2692000
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
2300000
CY2018 us-gaap Operating Lease Expense
OperatingLeaseExpense
1500000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1192000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7029000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
7244000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7458000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
7504000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
46607000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
77034000
CY2020 bill Online Bill Payment Products Expiration Month And Year
OnlineBillPaymentProductsExpirationMonthAndYear
2027-06
CY2020Q2 bill Service Agreement With Existing Financial Institution Partner Expanded Period
ServiceAgreementWithExistingFinancialInstitutionPartnerExpandedPeriod
P5Y
CY2020Q2 bill Agreed Amount Of Payment To Partner Under Service Agreement
AgreedAmountOfPaymentToPartnerUnderServiceAgreement
12000000.0
CY2020Q2 bill Amount Payable To Partner Under Service Agreement
AmountPayableToPartnerUnderServiceAgreement
10000000.0
CY2020Q2 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
13000000
CY2020Q2 us-gaap Other Commitment Due In Second Year
OtherCommitmentDueInSecondYear
2000000
CY2020Q2 us-gaap Other Commitment Due In Third Year
OtherCommitmentDueInThirdYear
2000000
CY2020Q2 us-gaap Other Commitment Due In Fourth Year
OtherCommitmentDueInFourthYear
2000000
CY2020Q2 us-gaap Other Commitment Due In Fifth Year
OtherCommitmentDueInFifthYear
2000000
CY2020Q2 us-gaap Other Commitment Due After Fifth Year
OtherCommitmentDueAfterFifthYear
3500000
CY2020Q2 us-gaap Other Commitment
OtherCommitment
24500000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-31091000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7314000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7195000
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44106000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7797000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7155000
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.70
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.94
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.01
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10160000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
62588000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
52862000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42110000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41230000
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39080000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35180000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31684000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28244000
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25999000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22424000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10100000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10110000
CY2019Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9787000
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9147000
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8488000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7914000
CY2018Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7175000
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6341000
CY2020Q2 us-gaap Gross Profit
GrossProfit
32010000
CY2020Q1 us-gaap Gross Profit
GrossProfit
31120000
CY2019Q4 us-gaap Gross Profit
GrossProfit
29293000
CY2019Q3 us-gaap Gross Profit
GrossProfit
26033000
CY2019Q2 us-gaap Gross Profit
GrossProfit
23196000
CY2019Q1 us-gaap Gross Profit
GrossProfit
20330000
CY2018Q4 us-gaap Gross Profit
GrossProfit
18824000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7899000
CY2018Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6154000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5424000
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11796000
CY2018Q3 us-gaap Gross Profit
GrossProfit
16083000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14929000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13969000
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12992000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11515000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9447000
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11802000
CY2019Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11491000
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10267000
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9949000
CY2019Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7365000
CY2018Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6856000
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5944000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15546000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15064000
CY2019Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12748000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10535000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8953000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7904000
CY2018Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6404000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5937000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
42271000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
40835000
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
37231000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
32317000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
28349000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
23168000
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
19414000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
17305000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-10261000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9715000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-7938000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6284000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5153000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2838000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-590000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1222000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
764000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1397000
CY2019Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
360000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
639000
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
596000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
734000
CY2018Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
686000
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
317000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9497000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8318000
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7578000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5645000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4557000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2104000
CY2018Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
96000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-905000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-59000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-70000
CY2018Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-21000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-9498000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-8319000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-7578000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-5696000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-4498000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-2034000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
102000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-884000
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.69
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.56
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12

Files In Submission

Name View Source Status
0001564590-20-041865-index-headers.html Edgar Link pending
0001564590-20-041865-index.html Edgar Link pending
0001564590-20-041865.txt Edgar Link pending
0001564590-20-041865-xbrl.zip Edgar Link pending
bill-10k_20200630.htm Edgar Link pending
bill-10k_20200630_htm.xml Edgar Link completed
bill-20200630.xsd Edgar Link pending
bill-20200630_cal.xml Edgar Link unprocessable
bill-20200630_def.xml Edgar Link unprocessable
bill-20200630_lab.xml Edgar Link unprocessable
bill-20200630_pre.xml Edgar Link unprocessable
bill-ex1014_505.htm Edgar Link pending
bill-ex211_84.htm Edgar Link pending
bill-ex231_140.htm Edgar Link pending
bill-ex311_86.htm Edgar Link pending
bill-ex312_85.htm Edgar Link pending
bill-ex321_87.htm Edgar Link pending
bill-ex322_88.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g035jmql12v1000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending